The Food and Drug Administration’s first-ever approval of an at-home test for chlamydia and gonorrhea could help drive earlier detection and treatment of these sexually transmitted infections amid a ...

Accessible testing for the infections may help curb the STI epidemic, but there is still a long way to go. By Laura Baisas Published Nov 28, 2023 3:30 PM EST Get the Popular Science daily newsletter💡 ...

Recent statistics show that the incidence of sexually transmitted infections (STIs) continues to rise. In 2021 alone, over 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported. The ...

Homosexual males at Tufts have been experiencing elevated rates of gonorrhea this semester, according to Medical Director of Tufts Health Service Margaret Higham. "[There has been a] significant rise ...

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain ...

This is a preview. Log in through your library . Abstract Background: The release of the first drug for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) in 2012 marked the beginning ...

This cross-sectional study of adults residing in New York City showed discrepancies between testing rates for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and HIV and their ...

The Food and Drug Administration authorized the first at-home test for chlamydia and gonorrhea Wednesday, which will increase Columbia’s testing options for both sexually transmitted infections. The ...

The Food and Drug Administration granted marketing approval to a home test for chlamydia and gonorrhea on Wednesday, the first such authorization of a home test to detect the two most common sexually ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that ...